Search - tctmd.com

Displaying 281 - 300 of 881

Sort: Relevancy | Date

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Daily News

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Todd Neale

July 27, 2015

News Industry News

Cardiome Partner Eddingpharm to Initiate BRINAVESS Phase I Study in China

July 24, 2015

News Daily News

FDA Sounds Alarm Bells Over Use of Lariat Device for LAA Closure in A-fib Patients

Yael L. Maxwell

July 17, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

L.A. McKeown

July 13, 2015

News Daily News

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

L.A. McKeown

July 13, 2015

News Industry News

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

July 13, 2015

News Daily News

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

Yael L. Maxwell

July 10, 2015

News Industry News

UK launch for Daiichi's bloodthinner Lixiana

July 10, 2015

Presentation

Perioperative Bridging Anticoagulation in Patients With A-fib

Presenter: JD. Douketis

July 09, 2015

News Daily News

Older Age Tied to Higher Risk of Recurrent Cerebral Ischemia in PFO Closure Patients

Yael L. Maxwell

July 08, 2015

News Daily News

Acute MI Arising From Coronary Embolism Rare, Often Tied to A-fib

L.A. McKeown

July 08, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

Single-Center Study Adds Further Data to Debate Over PFO Closure

July 06, 2015

News Industry News

Hansen Medical® Announces Successful Enrollment of Initial Cohort in Artisan® U.S. Clinical Trial

July 06, 2015

News Industry News

Biotronik launches Itrevia MRI-safe quad CRT-D in Japan

July 06, 2015

News Daily News

Statement on LAA Closure Highlights Key Issues for Growing Field

July 02, 2015

Advertisement

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Cardiome Partner Eddingpharm to Initiate BRINAVESS Phase I Study in China

FDA Sounds Alarm Bells Over Use of Lariat Device for LAA Closure in A-fib Patients

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

UK launch for Daiichi's bloodthinner Lixiana

Perioperative Bridging Anticoagulation in Patients With A-fib

Older Age Tied to Higher Risk of Recurrent Cerebral Ischemia in PFO Closure Patients

Acute MI Arising From Coronary Embolism Rare, Often Tied to A-fib

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

Single-Center Study Adds Further Data to Debate Over PFO Closure

Hansen Medical® Announces Successful Enrollment of Initial Cohort in Artisan® U.S. Clinical Trial

Biotronik launches Itrevia MRI-safe quad CRT-D in Japan

Statement on LAA Closure Highlights Key Issues for Growing Field

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content